Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
34.96B | 43.15B | 35.87B | 39.33B | 49.42B | 41.05B | Gross Profit |
5.40B | 8.25B | 4.63B | 5.20B | 3.40B | 2.71B | EBIT |
1.43B | 4.31B | 1.23B | 1.79B | 320.00M | -295.00M | EBITDA |
2.70B | 6.35B | 2.56B | 4.09B | 1.50B | 1.05B | Net Income Common Stockholders |
2.00B | 4.37B | 1.18B | 2.77B | 662.00M | 704.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.03B | 11.72B | 7.63B | 9.94B | 4.35B | 5.22B | Total Assets |
59.73B | 59.56B | 55.49B | 61.50B | 66.02B | 75.91B | Total Debt |
6.10B | 4.92B | 9.10B | 15.72B | 22.43B | 23.44B | Net Debt |
-1.93B | -6.81B | 1.46B | 5.78B | 18.08B | 18.21B | Total Liabilities |
26.97B | 27.06B | 28.20B | 37.02B | 44.70B | 53.46B | Stockholders Equity |
32.76B | 32.50B | 27.29B | 24.47B | 21.32B | 22.45B |
Cash Flow | Free Cash Flow | ||||
0.00 | 8.26B | 5.22B | 12.10B | -408.00M | 13.82B | Operating Cash Flow |
0.00 | 8.93B | 5.92B | 12.95B | 24.00M | 14.37B | Investing Cash Flow |
0.00 | 2.58B | -652.00M | -4.03B | -128.00M | 774.00M | Financing Cash Flow |
0.00 | -4.62B | -8.26B | -6.48B | -695.00M | -11.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥35.57T | 7.56 | 13.59% | 3.33% | 6.94% | 15.37% | |
77 Outperform | $17.52T | 28.67 | 10.50% | 1.06% | 0.56% | 5.32% | |
74 Outperform | ¥9.20T | 37.46 | 10.53% | 0.40% | 9.25% | 26.69% | |
69 Neutral | $1.39T | 15.74 | 12.94% | 1.73% | 15.31% | ― | |
66 Neutral | ¥10.56B | 5.27 | 3.26% | -9.30% | -19.61% | ||
64 Neutral | $4.36B | 12.05 | 5.23% | 249.94% | 4.13% | -10.23% | |
45 Neutral | $257.45B | ― | -77.14% | ― | 11.94% | -1374.36% |